These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 32626651)
1. Methylation Profile of X-Chromosome-Related Genes in Male Breast Cancer. Foschini MP; Morandi L; Sanchez AM; Santoro A; Mulè A; Zannoni GF; Varga Z; Moskovszky L; Cucchi MC; Moelans CB; Giove G; van Diest PJ; Masetti R Front Oncol; 2020; 10():784. PubMed ID: 32626651 [No Abstract] [Full Text] [Related]
2. X chromosome gain is related to increased androgen receptor expression in male breast cancer. Di Oto E; Biserni GB; Varga Z; Morandi L; Cucchi MC; Masetti R; Foschini MP Virchows Arch; 2018 Aug; 473(2):155-163. PubMed ID: 29802469 [TBL] [Abstract][Full Text] [Related]
3. Chromosome X aneusomy and androgen receptor gene copy number aberrations in apocrine carcinoma of the breast. Cremonini A; Saragoni L; Morandi L; Corradini AG; Ravaioli C; Di Oto E; Limarzi F; Sanchez AM; Cucchi MC; Masetti R; Quinn C; Foschini MP Virchows Arch; 2021 Aug; 479(2):345-354. PubMed ID: 33534004 [TBL] [Abstract][Full Text] [Related]
4. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055 [TBL] [Abstract][Full Text] [Related]
5. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report. Takuwa H; Tsuji W; Shintaku M; Yotsumoto F BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860 [TBL] [Abstract][Full Text] [Related]
6. The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer. Li C; Cao L; Xu C; Liu F; Xiang G; Liu X; Jiao J; Niu Y Hum Pathol; 2018 May; 75():16-25. PubMed ID: 29180246 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor gene alterations in Finnish male breast cancer. Syrjäkoski K; Hyytinen ER; Kuukasjärvi T; Auvinen A; Kallioniemi OP; Kainu T; Koivisto PA Breast Cancer Res Treat; 2003 Jan; 77(2):167-70. PubMed ID: 12602915 [TBL] [Abstract][Full Text] [Related]
8. Gain of androgen receptor gene copies in primary prostate cancer due to X chromosome polysomy. Röpke A; Erbersdobler A; Hammerer P; Palisaar J; John K; Stumm M; Wieacker P Prostate; 2004 Apr; 59(1):59-68. PubMed ID: 14991866 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor gene amplification and protein expression in recurrent prostate cancer. Ford OH; Gregory CW; Kim D; Smitherman AB; Mohler JL J Urol; 2003 Nov; 170(5):1817-21. PubMed ID: 14532783 [TBL] [Abstract][Full Text] [Related]
10. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Kinoshita H; Shi Y; Sandefur C; Meisner LF; Chang C; Choon A; Reznikoff CR; Bova GS; Friedl A; Jarrard DF Cancer Res; 2000 Jul; 60(13):3623-30. PubMed ID: 10910077 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment. Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458 [TBL] [Abstract][Full Text] [Related]
12. Gene-specific methylation profiles in Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Palli D; Ottini L Oncotarget; 2018 Apr; 9(28):19783-19792. PubMed ID: 29731982 [TBL] [Abstract][Full Text] [Related]
13. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin. Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer. de Kruijff IE; Sieuwerts AM; Onstenk W; Jager A; Hamberg P; de Jongh FE; Smid M; Kraan J; Timmermans MA; Martens JWM; Sleijfer S Int J Cancer; 2019 Aug; 145(4):1083-1089. PubMed ID: 30761532 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers. Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation-mediated transcriptional repression of TMPRSS2 in androgen receptor-negative prostate cancer cells. Chu M; Chang Y; Wang N; Li W; Li P; Gao WQ Exp Biol Med (Maywood); 2014 Jul; 239(7):823-828. PubMed ID: 24764242 [TBL] [Abstract][Full Text] [Related]
17. Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11. Younas K; Quintela M; Thomas S; Garcia-Parra J; Blake L; Whiteland H; Bunkheila A; Francis LW; Margarit L; Gonzalez D; Conlan RS J Mol Med (Berl); 2019 Sep; 97(9):1315-1327. PubMed ID: 31256208 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740 [TBL] [Abstract][Full Text] [Related]
19. Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer. Edwards J; Krishna NS; Mukherjee R; Watters AD; Underwood MA; Bartlett JM BJU Int; 2001 Oct; 88(6):633-7. PubMed ID: 11678763 [TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of Follistatin-Like 1 By the Androgen Receptor and Melanoma Antigen-A11 in Prostate Cancer. Su S; Parris AB; Grossman G; Mohler JL; Wang Z; Wilson EM Prostate; 2017 Apr; 77(5):505-516. PubMed ID: 27976415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]